Supernus Pharmaceuticals Net Change in Property, Plant, and Equipment 2011-2025 | SUPN
Supernus Pharmaceuticals net change in property, plant, and equipment from 2011 to 2025. Net change in property, plant, and equipment can be defined as the overall change in capital expenditures and sales of plant, property and equipment. This field is used if a company does not report separately sales and purchases of plant, property and equipment or is calculated as the sum of purchases and sales of PP&E
Supernus Pharmaceuticals Annual Net Change in Property, Plant, and Equipment
(Millions of US $) |
| 2024 |
$-1 |
| 2023 |
$-1 |
| 2022 |
$0 |
| 2021 |
$-2 |
| 2020 |
$-4 |
| 2019 |
$-1 |
| 2018 |
$-1 |
| 2017 |
$-2 |
| 2016 |
$-2 |
| 2015 |
$-2 |
| 2014 |
$-1 |
| 2013 |
$-2 |
| 2012 |
$-1 |
| 2011 |
$-1 |
| 2010 |
$0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$1.872B |
$0.662B |
|
Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. It is developing several product candidates in neurology and psychiatry to address opportunities in epilepsy and attention deficit hyperactivity disorder. Supernus Pharmaceuticals Inc. is based in Rockville, Maryland.
|
